Price (delayed)
$123.83
Market cap
$15.32B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.45
Enterprise value
$14.94B
Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a
There are no recent dividends present for NTRA.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.